Copyright
copy;2010 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2010; 16(39): 4892-4904
Published online Oct 21, 2010. doi: 10.3748/wjg.v16.i39.4892
Published online Oct 21, 2010. doi: 10.3748/wjg.v16.i39.4892
Short-term outcomes |
Toxic megacolon |
Colonic perforation |
Peritonitis with sepsis |
? Increased hospitalization duration and costs |
Colectomy rates highly variable |
Long-term outcomes |
Increased UC related hospitalization and emergency room visits |
? Escalation of medical treatment |
Increased rate of colectomy |
Features | Isolated CDI | CDI and IBD |
Setting | Often hospital acquired | Often community-acquired |
Risk factors | Antibiotic exposure prior to infection common | Many patients lacking of history of antibiotic exposure |
Immunomodulator and corticosteroid use | Immunomodulator and corticosteroid use playing even a greater role | |
Increasing age | Increasing age | |
Risk greater with ulcerative colitis than Crohn’s disease, more with colonic involvement than small bowel disease | ||
Clinical features | Usually watery diarrhea | May be bloody or mucous diarrhea |
Outcome | Short term complications including toxic megacolon, colonic perforation, and peritonitis with sepsis | Short term complications including toxic megacolon, colonic perforation, and peritonitis with sepsis similar to patients without IBD |
Hospitalization costs and length of stay variable in studies | ||
Increased mortality in some studies | ||
Risk of colectomy unclear | ||
Long term outcome unclear, increased hospitalizations and escalation in medication use and colectomy rates reported with retrospective data | ||
Diagnosis | ELISA testing for toxins | ELISA testing may be less sensitive |
Endoscopy and histology | Pseudomembranes common | Pseudomembranes rare |
Treatment | Metronidazole for mild to moderate severity | ? Vancomycin for any hospitalized IBD patient |
Vancomycin for severe disease | ||
Recurrence | 20% after the first episode of CDI | Rates highly variable 10%-58%, may be higher |
Extra-colonic gastrointestinal manifestations | Small bowel can be affected | Most cases of small bowel involvement in IBD patients |
Pouchitis can also be seen |
-
Citation: Navaneethan U, Venkatesh PG, Shen B.
Clostridium difficile infection and inflammatory bowel disease: Understanding the evolving relationship. World J Gastroenterol 2010; 16(39): 4892-4904 - URL: https://www.wjgnet.com/1007-9327/full/v16/i39/4892.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i39.4892